{"id":49098,"date":"2022-10-03T18:02:00","date_gmt":"2022-10-03T16:02:00","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/"},"modified":"2022-10-03T18:02:00","modified_gmt":"2022-10-03T16:02:00","slug":"companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/","title":{"rendered":"Companion Diagnostics Global Market Report 2022: Increasing Number of Targeted Therapies to Propel Growth &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5654248\/companion-diagnostics-global-market-report-2022?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=fxkc52&amp;utm_campaign=1757523+-+Companion+Diagnostics+Global+Market+Report+2022%3A++Increasing+Number+of+Targeted+Therapies+to+Propel+Growth&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Companion Diagnostics Global Market Report 2022&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221003005844\/en\/1590026\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221003005844\/en\/1590026\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global companion diagnostics market is expected to grow from $4.37 billion in 2021 to $5.15 billion in 2022 at a compound annual growth rate (CAGR) of 17.86%. The companion diagnostics market is expected to reach $9.99 billion in 2026 at a compound annual growth rate (CAGR) of 18.01%.\n<\/p>\n<p>\nNorth America was the largest region in the companion diagnostics market in 2021. The regions covered in the companion diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.\n<\/p>\n<p>\nThe increasing number of targeted therapies is expected to propel the growth of the companion diagnostics market. Targeted therapy is a pharmacological therapy that targets particular characteristics of cancer cells to inhibit the growth and spread of the disease.\n<\/p>\n<p>\nThe medications circulate throughout the body but have a more targeted effect than chemotherapy and frequently have fewer adverse effects. Biological marker-based companion diagnostic testing for targeted cancer therapy is becoming an essential part of personalized cancer care. According to the April 2021 article of European Society for Medical Oncology, the genome-targeted therapy estimated eligibility was 8.82% by the end of 2018 and increase to 13.60% in 2020. Therefore, the rising number of therapies drives the companion diagnostics market.\n<\/p>\n<p>\nTechnological advancement is a key trend in the companion diagnostics market. Artificial intelligence is used to develop more efficient drugs for companion diagnostics. The continuously gathered massive data sets from diverse genetic profiling have enabled the widespread application of AI.\n<\/p>\n<p>\nFor instance, Deep Genomics, a Toronto-based start-up, is utilizing artificial intelligence to uncover better medications for genetic illnesses and speed up their introduction into clinical trials. The goal is to employ deep learning to explore the human genome for knowledge about the causes of diseases and to create and test chemical compounds that can be used as remedies.\n<\/p>\n<p>\nIn a computer model, deep learning enables scientists to test billions of chemical compounds in search of promising formulations that they can turn into medicines that save lives for people worldwide.\n<\/p>\n<p>\nIn April 2021, Agilent Technologies Inc., a US-based Analytical laboratory company that manufactures instruments, reagents, software, services, and consumables for comprehensive laboratory workflow, acquired Resolution Bioscience for $695 million. With this acquisition, Agilent&#8217;s strengths in NGS-based cancer diagnostics are complements and expands, and also gives the company access to technology to meet the demands of the rapidly expanding precision medicine sector. Resolution Bioscience is a US-based healthcare research company specializing in NGS technology, molecular biology, cancer diagnostics, and more.\n<\/p>\n<p>\n<strong>Scope<\/strong>\n<\/p>\n<p>\n<strong>Markets Covered:<\/strong>\n<\/p>\n<p>\n1) By Product And Service: Assays, Kits And Reagents; Software And Services\n<\/p>\n<p>\n2) By Technology: Polymerase Chain Reaction; Next-Generation Sequencing; In Situ Hybridization; Immunohistochemistry\n<\/p>\n<p>\n3) By Indication: Lung Cancer; Breast Cancer; Colorectal Cancer; Leukemia; Melanoma\n<\/p>\n<p>\n4) By End-User: Pharmaceutical And Biopharmaceutical Companies; Reference Laboratories; Contract Research Organizations\n<\/p>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>2. Companion Diagnostics Market Characteristics<\/strong>\n<\/p>\n<p>\n<strong>3. Companion Diagnostics Market Trends And Strategies<\/strong>\n<\/p>\n<p>\n<strong>4. Impact Of COVID-19 On Companion Diagnostics<\/strong>\n<\/p>\n<p>\n<strong>5. Companion Diagnostics Market Size And Growth<\/strong>\n<\/p>\n<p>\n<strong>6. Companion Diagnostics Market Segmentation<\/strong>\n<\/p>\n<p>\n<strong>7. Companion Diagnostics Market Regional And Country Analysis<\/strong>\n<\/p>\n<p>\n<strong>8. Asia-Pacific Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>9. China Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>10. India Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>11. Japan Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>12. Australia Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>13. Indonesia Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>14. South Korea Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>15. Western Europe Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>16. UK Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>17. Germany Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>18. France Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>19. Eastern Europe Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>20. Russia Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>21. North America Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>22. USA Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>23. South America Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>24. Brazil Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>25. Middle East Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>26. Africa Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>27. Companion Diagnostics Market Competitive Landscape And Company Profiles<\/strong>\n<\/p>\n<p>\n<strong>28. Key Mergers And Acquisitions In The Companion Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>29. Companion Diagnostics Market Future Outlook and Potential Analysis<\/strong>\n<\/p>\n<p>\n<strong>30. Appendix<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nF Hoffmann-La Roche Ltd.\n<\/li>\n<li>\nAgilent Technologies Inc.\n<\/li>\n<li>\nQiagen NV\n<\/li>\n<li>\nThermo Fisher Scientific Inc.\n<\/li>\n<li>\nAbbott Laboratories Inc.\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5654248\/companion-diagnostics-global-market-report-2022?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=fxkc52&amp;utm_campaign=1757523+-+Companion+Diagnostics+Global+Market+Report+2022%3A++Increasing+Number+of+Targeted+Therapies+to+Propel+Growth&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/5gdxyp<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;&#108;&#116;o&#x3a;&#x70;&#x72;&#101;&#115;s&#64;&#x72;&#x65;&#x73;&#101;&#97;r&#x63;&#x68;&#x61;&#110;&#100;&#109;a&#x72;&#x6b;&#x65;&#116;&#115;&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#x65;&#115;&#115;&#64;re&#x73;&#x65;&#x61;&#x72;&#99;&#104;an&#x64;&#x6d;&#x61;&#x72;&#107;&#101;ts&#x2e;&#x63;&#x6f;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Companion Diagnostics Global Market Report 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global companion diagnostics market is expected to grow from $4.37 billion in 2021 to $5.15 billion in 2022 at a compound annual growth rate (CAGR) of 17.86%. The companion diagnostics market is expected to reach $9.99 billion in 2026 &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49098","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Companion Diagnostics Global Market Report 2022: Increasing Number of Targeted Therapies to Propel Growth - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Companion Diagnostics Global Market Report 2022: Increasing Number of Targeted Therapies to Propel Growth - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Companion Diagnostics Global Market Report 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global companion diagnostics market is expected to grow from $4.37 billion in 2021 to $5.15 billion in 2022 at a compound annual growth rate (CAGR) of 17.86%. The companion diagnostics market is expected to reach $9.99 billion in 2026 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-03T16:02:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221003005844\/en\/1590026\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Companion Diagnostics Global Market Report 2022: Increasing Number of Targeted Therapies to Propel Growth &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-10-03T16:02:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\\\/\"},\"wordCount\":692,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221003005844\\\/en\\\/1590026\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\\\/\",\"name\":\"Companion Diagnostics Global Market Report 2022: Increasing Number of Targeted Therapies to Propel Growth - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221003005844\\\/en\\\/1590026\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-10-03T16:02:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221003005844\\\/en\\\/1590026\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221003005844\\\/en\\\/1590026\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Companion Diagnostics Global Market Report 2022: Increasing Number of Targeted Therapies to Propel Growth &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Companion Diagnostics Global Market Report 2022: Increasing Number of Targeted Therapies to Propel Growth - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Companion Diagnostics Global Market Report 2022: Increasing Number of Targeted Therapies to Propel Growth - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Companion Diagnostics Global Market Report 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global companion diagnostics market is expected to grow from $4.37 billion in 2021 to $5.15 billion in 2022 at a compound annual growth rate (CAGR) of 17.86%. The companion diagnostics market is expected to reach $9.99 billion in 2026 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-03T16:02:00+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221003005844\/en\/1590026\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Companion Diagnostics Global Market Report 2022: Increasing Number of Targeted Therapies to Propel Growth &#8211; ResearchAndMarkets.com","datePublished":"2022-10-03T16:02:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/"},"wordCount":692,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221003005844\/en\/1590026\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/","name":"Companion Diagnostics Global Market Report 2022: Increasing Number of Targeted Therapies to Propel Growth - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221003005844\/en\/1590026\/21\/logo.jpg","datePublished":"2022-10-03T16:02:00+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221003005844\/en\/1590026\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221003005844\/en\/1590026\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/companion-diagnostics-global-market-report-2022-increasing-number-of-targeted-therapies-to-propel-growth-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Companion Diagnostics Global Market Report 2022: Increasing Number of Targeted Therapies to Propel Growth &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49098","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49098"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49098\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49098"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49098"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49098"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}